Azora Therapeutics appoints Habtezion, Hastings and Soloway to board
AZR•Azora Therapeutics appointed Aida Habtezion, Paul Hastings and Thomas Soloway to its board on November 3, 2026.
1. Board appointments
Habtezion, formerly Pfizer’s chief medical officer, has a board term expiring at the 2028 annual meeting. Hastings, Nkarta’s CEO, chairs the nominating and corporate governance committee, while Soloway, T-knife Therapeutics’ CEO, chairs the audit committee; both board terms expire at the 2029 annual meeting.
2. Committee roles
Wendy Young chairs the compensation committee, joined by Soloway and Habtezion. Young and Hastings also joined the audit committee.
